Published in Stat Med on December 30, 2008
Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA (2001) 8.72
A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics (2001) 7.09
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (1995) 6.85
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2001) 5.36
Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol (2000) 5.24
Development of a model for training and evaluation of laparoscopic skills. Am J Surg (1998) 5.02
Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (1992) 4.75
Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann Intern Med (1995) 4.54
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum (1996) 3.40
Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ (1995) 3.40
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
Questionable prescribing for elderly patients in Quebec. CMAJ (1994) 3.01
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91
DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell (1998) 2.81
Automatic record hash coding and linkage for epidemiological follow-up data confidentiality. Methods Inf Med (1998) 2.80
The Quebec Back Pain Disability Scale. Measurement properties. Spine (Phila Pa 1976) (1995) 2.75
Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.74
Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene (2009) 2.74
Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem (1995) 2.67
HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat Med (1997) 2.56
Evaluation of the effectiveness of immunization delivery methods. Can J Public Health (1995) 2.36
The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol (1995) 2.32
Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique (2003) 2.25
An approach to the development of practice guidelines for community health interventions. Can J Public Health (1995) 2.24
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity (1995) 2.19
Etiologic yield of subspecialists' evaluation of young children with global developmental delay. J Pediatr (2000) 2.10
The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA (1992) 1.98
Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer (1998) 1.96
Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS (1998) 1.95
Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique (2008) 1.88
Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum (2001) 1.87
Evaluation of rubella screening in pregnant women. CMAJ (1998) 1.81
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Association between licensing examination scores and resource use and quality of care in primary care practice. JAMA (1998) 1.76
Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies? J Rheumatol (1996) 1.67
Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med (2001) 1.66
Tobacco, alcohol, and colorectal tumors: a multistep process. Am J Epidemiol (1995) 1.65
Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. The Association Nationale des Gastroentérologues des Hôpitaux and Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505) Gastroenterology (1998) 1.62
Life expectancy following dietary modification or smoking cessation. Estimating the benefits of a prudent lifestyle. Arch Intern Med (1994) 1.59
Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg (2006) 1.59
Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol (2000) 1.59
How to ensure data security of an epidemiological follow-up: quality assessment of an anonymous record linkage procedure. Int J Med Inform (1998) 1.58
Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther (2005) 1.58
Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol (2000) 1.57
Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Prev Med (1998) 1.55
Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg (2002) 1.48
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Etiologic yield of single domain developmental delay: a prospective study. J Pediatr (2000) 1.43
Extraction and anonymity protocol of medical file. Proc AMIA Annu Fall Symp (1996) 1.41
Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet (2008) 1.41
[Appendectomy, cholecystectomy, cholelithiasis and colorectal cancer. A retrospective case control study at the Côte-d'Or]. Gastroenterol Clin Biol (1991) 1.40
Clinical parameters to predict response to interferon in relapsing multiple sclerosis. Neuroepidemiology (2008) 1.40
Comparison of the ability of alternative birthweight and fetal weight standards to identify preterm newborns at increased risk of perinatal death. BJOG (2013) 1.40
[How to choose in practice a model to describe the geographic variation of cancer incidence? Example of gastrointestinal cancers from Côte-d'Or]. Rev Epidemiol Sante Publique (2002) 1.39
Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut (2004) 1.39
Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum (2004) 1.38
Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer (2001) 1.38
[A diagnostic strategy for isolated pulmonary nodules less than 2 cm in diameter]. Rev Mal Respir (2002) 1.37
[Disposable versus reusable biopsy forceps. A prospective cost analysis in the gastrointestinal endoscopy unit of the Dijon University Hospital]. Gastroenterol Clin Biol (2001) 1.37
Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg (1995) 1.34
Environmental risk factors for delirium in hospitalized older people. J Am Geriatr Soc (2001) 1.34
Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol (1999) 1.34
Colon cancer in France: evidence for improvement in management and survival. Gut (2002) 1.34
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer (2006) 1.33
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Reanalysis of the Harvard Six Cities Study, part II: sensitivity analysis. Inhal Toxicol (2005) 1.30
Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int J Cancer (1998) 1.29
Adenoma--carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer (1992) 1.28
European health systems and cancer care. Ann Oncol (2003) 1.27
Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev (2004) 1.25
Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death. J Immunol (1999) 1.24
A flexible modeling approach to estimating the component effects of smoking behavior on lung cancer. J Clin Epidemiol (2004) 1.23
The feasibility and value of using patient satisfaction ratings to evaluate internal medicine residents. J Gen Intern Med (1994) 1.22
Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer (2000) 1.22
First-visit bias in the measurement of clinical competence with standardized patients. Acad Med (1992) 1.20
Use of standardized patients to assess between-physician variations in resource utilization. JAMA (1997) 1.19
Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect (2003) 1.19
Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg (2008) 1.17
Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis (2013) 1.15
The Quebec Back Pain Disability Scale: conceptualization and development. J Clin Epidemiol (1996) 1.15
Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds. The EVA Study Group. Stroke (1996) 1.15
Influence of socioeconomic status on prognosis of colorectal cancer. A population-based study in Côte D'Or, France. Cancer (1993) 1.14
Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke (1999) 1.14
Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals. Immunol Rev (1994) 1.12
Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening. Br J Cancer (2001) 1.12
[Factors of early prognosis in medically treated haemorrhages of upper gastrointestinal tract in cirrhotic patients. Statistical study (author's transl)]. Pathol Biol (Paris) (1981) 1.12
Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer (1997) 1.12
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Improvement of operative mortality after curative resection for gastric cancer: population-based study. World J Surg (2000) 1.11
Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol (1993) 1.11